Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 22, 1999
Grant Date -
N/A
app pub date -
Jun 2, 1998
filing date -
Jun 2, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of controlling the serum solubility of orally administered torasemide is disclosed. A new crystallin modification of torasemide, called modification III which has significantly higher rates of solubilization than the known crystallin form of torasemide, modification I, is blended with amounts of modification I to produce a preselected level of torasemide in serum at a given time following administration. Compositions containing amounts of modification I and modification III, sufficient to achieve the desired serum levels of torasemide, are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully